Codes and Frequencies
Description
AIDHRDRUGHELP (V837) indicates whether the woman had heard of medicine to help people with HIV/AIDS. How such drugs were labeled and how their effects were described varies across samples. See Comparability.
Comparability — Index
|
GENERAL Benin Congo Brazzaville |
Ethiopia Lesotho Niger |
Senegal Zimbabwe |
Comparability
Along with universe differences, AIDHRDRUGHELP (V837) has some differences in question wording across samples. For example, some surveys refer broadly to "special drugs/medication," while others refer more narrowly to "antiretroviral drugs" (and may mention local names of specific drugs). Many, but not all, surveys specify that the drugs help recipients live longer. Surveys that did not specify whether the drugs will help people infected with HIV/AIDS live longer are noted below. Users concerned with drug wording variations should consult the Survey Text tab for samples of interest.
Comparability - Standard DHS
AIDHRDRUGHELP (V837) is included in Phase V and Phase VIII of the standard DHS questionnaire.
Comparability — Benin [top]
The 2006 Benin survey does not specify whether the drugs will allow an infected person to "live longer."
Comparability — Congo Brazzaville [top]
The 2005 Republic of the Congo - Brazzaville survey does not specify whether the drugs will allow an infected person to "live longer."
Comparability — Ethiopia [top]
The 2005 Ethiopia survey does not specify whether the drugs will allow an infected person to "live longer."
Comparability — Lesotho [top]
The 2004 Lesotho survey asks, "Is there any special medication that people infected with the AIDS virus can get from a doctor or a nurse?" The 2009 Lesotho includes the more standard question wording, "Have you heard about special antiretroviral drugs (ART) that people infected with the AIDS virus can get from a doctor or a nurse to help them live longer?"
Comparability — Niger [top]
The 2006 Niger survey does not specify whether the drugs will allow an infected person to "live longer."
Comparability — Senegal [top]
The 2005 Senegal survey does not specify whether the drugs will allow an infected person to "live longer."
Comparability — Zimbabwe [top]
The 2005 Zimbabwe survey does not specify whether the drugs will allow an infected person to "live longer."
Universe
- Benin 2006: Women age 15-49 who have heard of HIV/AIDS.
- Congo (Democratic Republic) 2007: Women age 15-49 who have heard of HIV/AIDS.
- Congo Brazzaville 2005: Women age 15-49 who have heard of HIV/AIDS and answered "Yes" to any of 3 questions about whether HIV can be transmitted mother to baby through pregnancy, delivery or breastfeeding.
- Eswatini (Swaziland) 2006: Women age 15-49 who have heard of HIV/AIDS.
- Ethiopia 2005: Women age 15-49 whose households were selected for the male survey and have heard of HIV/AIDS.
- Ghana 2008: Women age 15-49 who have heard of HIV/AIDS.
- Guinea 2005: Women age 15-49 who have heard of HIV/AIDS.
- India 2005: Women age 15-49 who have heard of HIV/AIDS.
- India 2015: Women age 15-49 who have heard of HIV/AIDS, in households selected for the state module.
- India 2019: Women age 15-49 who have heard of HIV/AIDS, in households selected for the state module.
- Lesotho 2004: Women age 15-49 who have heard of HIV/AIDS.
- Lesotho 2009: Women age 15-49 who have heard of HIV/AIDS.
- Liberia 2007: Women age 15-49 who have heard of HIV/AIDS.
- Malawi 2010: Women age 15-49 who have heard of HIV/AIDS.
- Mali 2006: Women age 15-49 who have heard of HIV/AIDS.
- Namibia 2006: Women age 15-49 who have heard of HIV/AIDS.
- Niger 2006: Women age 15-49 who have heard of HIV/AIDS.
- Nigeria 2008: Women age 15-49 who have heard of HIV/AIDS.
- Sao Tome 2008: Women age 15-49 who have heard of HIV/AIDS.
- Senegal 2005: Women age 15-49 who have heard of HIV/AIDS.
- Sierra Leone 2008: Women age 15-49 who have heard of HIV/AIDS.
- Tanzania 2004: Women age 15-49 who have heard of HIV/AIDS.
- Uganda 2006: Women age 15-49 who have heard of HIV/AIDS.
- Zambia 2007: Women age 15-49 who have heard of HIV/AIDS.
- Zimbabwe 2005: Women age 15-49 who have heard of HIV/AIDS.
